Another study revealed, in MSS CRC cell lines and tissues, that IL-17A, secreted by Th17 cells, increased expression of PD-L1 on CRC cells and that inhibition of IL-17A improved the efficacy of anti-PD-1 therapy in a murine MSS CRC model [181]. This evidence concerns the gene IL17A and colorectal carcinoma.